2.21 USD
↘ 0.11 (4.55%)LIVE (AS OF 01:21 PM EDT)
Shares of Compugen Ltd (CGEN) are trading at $2.21. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Oct 5, 2026.
Open?$2.32
High?$2.34
Low?$2.21
Prev. Close?$2.31
Volume?168.9K
Avg. Volume?N/A
VWAP?$2.28
Bid / Ask
Bid?$2.22 × 300
Ask?$2.23 × 600
Spread?$0.01
Midpoint?$2.23
Valuation & Ratios
Market Cap?218.8M
Shares Out?N/A
Float?93.5M
Float %?99.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Themes
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?2.53%Low
Short Interest?2.4M
Days to Cover?12.0
Free Float93.5M
Avg Daily Volume197.0K
Settlement Date2026-09-15